Skip to main content

Cenobamate Disease Interactions

There are 4 disease interactions with cenobamate.

Major

Cenobamate (applies to cenobamate) short QT syndrome

Major Potential Hazard, Moderate plausibility.

Cenobamate causes QT interval shortening. The use of this drug is contraindicated in patients with familial short QT syndrome, as it is associated with an increased risk of sudden death and ventricular arrhythmias, particularly ventricular fibrillation.

Switch to professional interaction data

Moderate

Antiepileptics (applies to cenobamate) suicidal tendency

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Depression, Psychosis

Antiepileptic drugs (AEDs) have been associated with an increased risk of suicidal thoughts or behavior in patients taking these drugs for any indication. Pooled analyses of 199 placebo-controlled clinical studies involving the use of 11 different AEDs showed that patients receiving AEDs had approximately twice the risk of suicidal thinking or behavior compared to patients receiving placebo. AEDs should be administered cautiously in patients with depression or other psychiatric disorders; phentermine-topiramate should be avoided in patients with history of suicidal attempts or active suicidal ideation. The risk of suicidal thoughts and behavior should be carefully assessed against the risk of untreated illness, bearing in mind that epilepsy and many other conditions for which AEDs are prescribed are themselves associated with morbidity and mortality and an increased risk of suicidal thoughts and behavior. Patients, caregivers, and families should be alert to the emergence or worsening of signs and symptoms of depression, any unusual changes in mood or behavior, or the emergence of suicidal thoughts or behavior. If patients have symptoms of suicidal ideation or behavior, a dosage reduction or treatment discontinuation should be considered.

Switch to professional interaction data

Moderate

Cenobamate (applies to cenobamate) hepatic dysfunction

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease

Cenobamate should be used with caution in patients with mild to moderate hepatic dysfunction. Consider a dosage reduction in these patients, with a maximum recommended dosage of 200 mg once a day. The use in patients with severe hepatic dysfunction is not recommended.

Switch to professional interaction data

Moderate

Cenobamate (applies to cenobamate) renal dysfunction

Moderate Potential Hazard, Moderate plausibility.

Cenobamate should be used with caution and dosage reduction may be considered in patients with renal dysfunction. The use in patients with end-stage renal disease undergoing dialysis is not recommended.

Switch to professional interaction data

Cenobamate drug interactions

There are 578 drug interactions with cenobamate.

Cenobamate alcohol/food interactions

There is 1 alcohol/food interaction with cenobamate.

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer